Clinical Trial Update: Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ultrasonographic monitoring of response to infliximab in rheumatoid arthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Rheumatoid Arthritis, Ultrasonography | Phase 4 | Status: UNKNOWN